EXECUTIVE SUMMARY
The business operates as a specialised telehealth platform delivering medicinal cannabis consultations across Australia through TGA-compliant processes and qualified healthcare practitioners. The business has established strong foundations including operational telehealth infrastructure, active patient database, comprehensive clinical documentation, and strategic pharmacy partnerships generating recurring revenue streams.
The company seeks AUD $220,000 for complete equity acquisition, offering investors immediate ownership of a turnkey operation with proven market traction. Current business model generates revenue through initial consultations, follow-up appointments, and ongoing prescription management, whilst maintaining lean operational structure through strategic outsourcing. Key differentiators include automated systems, established compliance frameworks, and developing vertical integration opportunities. Market positioning leverages growing patient acceptance of medicinal cannabis alternatives, supportive regulatory environment, and increasing healthcare digitisation trends. The acquisition includes comprehensive handover support, ensuring seamless operational transition and continued growth trajectory.
HISTORY AND KEY BUSINESS MILESTONES
Company incorporation completed with comprehensive regulatory compliance framework established. Initial investment of AUD $59,000 allocated to compliance setup, legal structures, and foundational business processes ensuring TGA adherence.
First qualified Nurse Practitioner onboarded under contractor model, enabling commencement of clinical telehealth consultations. Operational protocols established including patient assessment procedures, prescription management workflows, and quality assurance frameworks.
Official website launch accompanied by TGA-compliant marketing campaign implementation. Digital infrastructure deployment included patient management systems, consultation platforms, and automated administrative processes designed for scalable operations.
Strategic pharmacy partnerships secured with major Australian cannabis industry suppliers, establishing recurring revenue stream of AUD $2,500 monthly. Commercial agreements encompass product sourcing, patient fulfilment services, and ongoing supplier relationship management, positioning the business for sustainable growth and enhanced patient care delivery.
Opportunities
Rapidly expanding Australian medicinal cannabis market projected to exceed AUD $400 million by 2028, increasing patient acceptance of alternative therapies, potential vertical integration into product manufacturing and distribution, expansion into complementary healthcare services including mental health and functional medicine, and strategic partnership opportunities with larger healthcare organisations.
Established TGA-compliant operational infrastructure, proven patient acquisition channels, qualified clinical team, strategic pharmacy partnerships generating recurring revenue, lean operational structure, automated systems reducing administrative overhead, and founders with demonstrated healthcare industry expertise.
OUR PRODUCTS OR SERVICE
- Primary Services
- Clinical Processes
- Technology Platform
- Future Expansion
SALE PRICE
The AUD $220,000 investment represents a complete equity acquisition providing full ownership transfer to the acquiring party. Capital allocation encompasses founder compensation for business transfer, comprehensive operational handover support, and strategic advisory services during transition period.
We welcome further discussions regarding this investment opportunity and look forward to providing additional information supporting your investment decision. Thank you for considering Herbal Hub Pty Ltd as your strategic healthcare investment partner.
